Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial.
Ashenafi Shumey CherkosSylvia M LaCourseDaniel A EnquobahrieJaclyn N EscuderoJerphason MechaDaniel MatemoJohn KinuthiaSarah J IribarrenGrace C John-StewartPublished in: PloS one (2024)
IPT administered to HEU infants did not significantly impact growth outcomes in the first two years of life.
Keyphrases
- hiv infected
- antiretroviral therapy
- mycobacterium tuberculosis
- human immunodeficiency virus
- hiv positive
- young adults
- hepatitis c virus
- hiv testing
- hiv aids
- big data
- weight gain
- machine learning
- metabolic syndrome
- men who have sex with men
- body mass index
- adipose tissue
- physical activity
- bone marrow
- artificial intelligence
- insulin resistance
- weight loss
- smoking cessation